This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.
AI is now as much a part of U.S. healthcare as any other technology category in wide use across the sector. However, like no other technology, its role is “being actively shaped, not passively adopted” by clinicians and patients alike.
A recent OIG report suggested vascular surgeons, interventional cardiologists and interventional radiologists may be performing medically unnecessary procedures in office-based labs. Now, some of the leading medical societies from those fields have provided additional context.
Asking medical questions of AI with language spoken “in the wild”—meaning with LLM prompts from everyday consumers—brings back answers with decidedly mediocre accuracy, a new study shows.
It may hold that applying established people/process/technology principles can help hospitals move AI from experimental research settings to regulated clinical practice.
"This practice has been adopted by multiple organ-procurement organizations and is used on thousands of organ donors each year, without ever having been rigorously studied," one researcher said.
GLP-1 agonists are often taken as daily or weekly injections. A new delivery system could help make it so those same drugs are only required three times per year.
While TAVR and SAVR are reliable treatments for calcific aortic stenosis, some patients are not considered for those procedures due to severe comorbidities or a limited life expectancy. This is where the investigational Valvosoft device from Cardiawave enters the equation.